<DOC>
	<DOCNO>NCT01798550</DOCNO>
	<brief_summary>The purpose study determine effective enoxaparin dose strategy medically ill , morbidly obese patient . This study include adult patient great 18 yrs age admit Grady Hospital Atlanta , GA . Potentially vulnerable patient prisoner , child , pregnant woman enrol study . Study participant contact person study personnel inclusion criterion meet . Written inform consent obtain person hospitalize . Once patient consent give enoxaparin blood sample draw . The data collect electronic medical record access username password publicly available . The data identifiable upon collection keep password protect file computer lock office . The data de-identified data analysis study personnel access code link identifier subject . A HIPAA waiver request access exist data order identify patient enrollment . All data collect office hospital . The study participant ' burden minimal dependent time consent process since morbidly obese patient would receive blood sample collection regardless participation study .</brief_summary>
	<brief_title>Enoxaparin Dosing Obesity</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<criteria>Planned treat twice daily enoxaparin BMI &gt; = 40 kg/m2 &lt; 18 year age CrCl &lt; 30 ml/min Pregnancy Prisoner Active bleed Already receive 3 consecutive dos enoxaparin Use therapeutic enoxaparin 5 consecutive day within last 3 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Enoxaparin dosing</keyword>
	<keyword>Obesity</keyword>
</DOC>